AMED - Amedisys Inc

Industry: Home Health Care Sector: Healthcare Exchange: NASDAQ

AMED - Amedisys Inc

Industry: Home Health Care Sector: Healthcare Exchange: NASDAQ

Tue 18'th Sep 2018

PERIOD 2018-06-19 - 2018-09-18
CHANGE 0.51%
PRICE $120.10





Request Prediction

Amedisys Inc Stock Analysis

Technical stock analysis for Tue 18'th Sep 2018

Buy candidate since 2018-08-31 Loss -3.93%
Shorts 2.18% ( 2018-08-31 )
Cash 66.1 mill
Loans 89.9 mill
Beta 1.01
ROA 9.14

Amedisys Inc gained 0.51% in the last trading day, rising from $119.49 to $120.10 The price has been going up and down for this period, and there has been a -3.83% loss for the last 2 weeks. Volume fell in the last day by -28 780 shares, and in total, 247 362 shares bought and sold for approximately $29.71 million. You should take into consideration that a falling volume on higher prices causes divergence and may be an early warning about possible changes for the next couple of days.


Amedisys Inc lies in the lower part of a wide and strong rising trend in the short term, and this will normally pose a very good buying opportunity. A break down the bottom trend line at $119.40 will firstly indicate a slower raising rate, but may also be a early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 52.4% during the next 3 months and, with 90% probability hold a price between $181.96 and $207.09 at the end of this period.

Click here for today's Top 5 Trending Companies


Only positive signals in the chart today. Amedisys Inc holds a sales signal from the short-term moving average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock. On further gains, the stock will meet resistance from the short-term moving average at approximately $121.48. On a fall, the stock will find some support from the long-term average at approximately $117.66. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sales signal. A buy signal was issued from a pivot bottom point on Monday September 17, 2018, which indicates further gains until a new top pivot has been found. Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and may be an early warning. The stock should be watched closely.

Access today's Top 5 Golden Star Companies

A sell signal from a double bottom formation was found on Tuesday September 11, 2018 with a target of $120.84. Despite the objective of the signal formation has been reached the stock may continue to fall.

Relative Strength Index (RSI)

RSI14 is 44 and the stock is currently not being overbought or oversold

Access full RSI 14 and RSI 21 lists

Support & Resistance

On the downside, the stock finds support just below today's level from accumulated volume at $106.01 and $103.82.

There is natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Amedisys Inc finds support just below today's level at $106.01. If this is broken, then the next support from accumulated volume will be at $103.82 and $93.63.

Support: $106.01 Price: $120.10 Resistance: $120.53


This stock is usually traded at good volume, and with minor daily changes the risk is considered to be low. During the last day, the stock moved $2.30 (1.92%) between high and low. For the last week, the stock has had a daily average volatility of 2.70%.

Our recommended stoploss: $113.37 (-5.61%) (This stock has low daily movements and this gives low risk. There is a buy signal from pivot bottom found 1 days ago.)

Overall risk:

Very Low Low Medium High Very High


Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for this stock to perform well in the short-term.

Buy Candidate

Click for Top 5 Buy Candidates
AMED $120.10 $0.61(0.51%)
AMED is up $0.61 today, but where's it headed in October?
Zacks Investment Research is releasing its prediction for AMED based on the 1-3 month system that more than doubles the S&P 500.

Click here – the AMED analysis is free »

Last donation

Do you find our website useful too?
Help us improve by making a small donation or
Get PRO features

Proudly made at

in partnership with